Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective study

Journal of the American Academy of Dermatology

Volumn 70, Issue 6, 2014, Pages 1146-1149

  Tauber, Marie ^a   Buche, Sébastien ^b   Reygagne, Pascal ^a   Berthelot, Jean Marie ^c   Aubin, François ^d   Ghislain, Pierre Dominique ^e   Cohen, Jean David ^f   Coquerelle, Pascal ^g   Goujon, Elisa ^h   Jullien, Denis ⁱ   Brixi, Hedia ^j   Jeudy, Géraldine ^k   Guennoc, Xavier ^h   Martin, Antoine ^h   Brénaut, Emilie ^l   Hoppé, Emmanuel ^m   Bertolotti, Antoine ⁿ   Bardin, Thomas ^o   Delaporte, Emmanuel ^b   Allez, Matthieu ^o   Bachelez, Hervé ^a   Seneschal, Julien ⁿ   Viguier, Manuelle ^a   more..

^a SAINT LOUIS HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e Hôpital Louvain   (Belgium)

^f MONTPELLIER UNIVERSITY HOSPITAL   (France)

^g Groupe Hospitalier Sud Réunion GHSR   (France)

^h CHR   (France)

ⁱ HOSPICES CIVILS DE LYON   (France)

^j REIMS UNIVERSITY HOSPITAL   (France)

^k DIJON UNIVERSITY HOSPITAL   (France)

^l BREST UNIVERSITY HOSPITAL   (France)

^m ANGERS UNIVERSITY HOSPITAL   (France)

ⁿ HÔPITAL SAINT ANDRÉ   (France)

^o UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALOPECIA AREATA; CLINICAL ARTICLE; FEMALE; HASHIMOTO DISEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; LETTER; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; PSORIASIS; RHEUMATIC DISEASE; VITILIGO; AGE DISTRIBUTION; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CLINICAL TRIAL; COHORT ANALYSIS; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; FRANCE; INCIDENCE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO;

ADULT; AGE DISTRIBUTION; ALOPECIA AREATA; ANTIBODIES, MONOCLONAL, HUMANIZED; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901044685     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.03.005     Document Type: Article

References (5)

1. M. Ferran, J. Calvet, M. Almirall, R.M. Pujol, and J. Maymó Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents: report of five cases and review of the literature J Eur Acad Dermatol Venereol 25 2011 479 484
2. E. Le Bidre, G. Chaby, L. Martin, M. Perrussel, B. Sassolas, and M.L. Sigal et al. Pelade au cours d'un traitement par anti-TNF alpha: neuf cas Ann Dermatol Venereol 138 2011 285 293
3. J.J. Wu, T.U. Nguyen, K.Y. Poon, and L.J. Herrinton The association of psoriasis with autoimmune diseases J Am Acad Dermatol 67 2012 924 930
4. L. Petukhova, M. Duvic, M. Hordinsky, D. Norris, V. Price, and Y. Shimomura et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity Nature 466 2010 113 117
5. E. Shmidt, D.A. Wetter, S.B. Ferguson, and M.R. Pittelkow Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010 J Am Acad Dermatol 67 2012 e179 e185